In ACS-AKI, IL-6 may limit tissue loss by inducing anti-apoptotic pathways; however, the continuous IL-6 expression might also lead to deleterious effects via reduced expression of SOCS3 and increased neutrophilic recruitment [31]. The gene discussed is SOCS3; the disease is acute kidney injury.